Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M13,064Revenue $M6,012Net Margin (%)6.3Altman Z-Score1.9
Enterprise Value $M19,581EPS $5.9Operating Margin %13.1Piotroski F-Score4
P/E(ttm)27.3Beneish M-Score-2.1Pre-tax Margin (%)10.5Higher ROA y-yN
Price/Book2.810-y EBITDA Growth Rate %10.4Quick Ratio1.5Cash flow > EarningsY
Price/Sales1.85-y EBITDA Growth Rate %5.9Current Ratio1.7Lower Leverage y-yN
Price/Free Cash Flow32.2y-y EBITDA Growth Rate %-1.6ROA % (ttm)4.7Higher Current Ratio y-yN
Dividend Yield %--PEG4.6ROE % (ttm)13.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M100ROIC % (ttm)7.0Gross Margin Increase y-yN

Gurus Latest Trades with LH

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LHWallace Weitz 2015-03-31 Reduce-0.75%$110.6 - $128.18
($119.7)
$ 126.326%Reduce 25.12%746,258
LHChris Davis 2015-03-31 Reduce-0.53%$110.6 - $128.18
($119.7)
$ 126.326%Reduce 25.05%4,443,459
LHCharles Brandes 2015-03-31 Sold Out -0.18%$110.6 - $128.18
($119.7)
$ 126.326%Sold Out0
LHJoel Greenblatt 2015-03-31 Reduce-0.16%$110.6 - $128.18
($119.7)
$ 126.326%Reduce 63.43%104,024
LHRichard Pzena 2015-03-31 Reduce-0.06%$110.6 - $128.18
($119.7)
$ 126.326%Reduce 12.35%728,078
LHJohn Rogers 2015-03-31 Add0.03%$110.6 - $128.18
($119.7)
$ 126.326%Add 1.31%1,404,802
LHJohn Keeley 2015-03-31 Buy 0.03%$110.6 - $128.18
($119.7)
$ 126.326%New holding10,760
LHMario Gabelli 2015-03-31 Add$110.6 - $128.18
($119.7)
$ 126.326%Add 25.00%5,000
LHRichard Pzena 2014-12-31 Reduce-0.41%$97.81 - $109.58
($102.65)
$ 126.3223%Reduce 46.70%830,648
LHCharles Brandes 2014-12-31 Reduce-0.06%$97.81 - $109.58
($102.65)
$ 126.3223%Reduce 28.96%117,707
LHTom Gayner 2014-12-31 Sold Out -0.04%$97.81 - $109.58
($102.65)
$ 126.3223%Sold Out0
LHJohn Rogers 2014-09-30 Add0.39%$102.01 - $108.25
($105.23)
$ 126.3220%Add 27.74%1,389,464
LHJoel Greenblatt 2014-09-30 Add0.32%$102.01 - $108.25
($105.23)
$ 126.3220%Add 11552.50%317,530
LHChris Davis 2014-09-30 Reduce-0.24%$102.01 - $108.25
($105.23)
$ 126.3220%Reduce 11.23%5,989,780
LHChris Davis 2014-06-30 Reduce-0.78%$98.21 - $104.67
($100.8)
$ 126.3225%Reduce 29.99%6,747,256
LHRichard Pzena 2014-06-30 Reduce-0.35%$98.21 - $104.67
($100.8)
$ 126.3225%Reduce 26.69%1,654,529
LHJoel Greenblatt 2014-06-30 Reduce-0.08%$98.21 - $104.67
($100.8)
$ 126.3225%Reduce 95.40%2,725
LHTom Gayner 2014-06-30 Buy 0.04%$98.21 - $104.67
($100.8)
$ 126.3225%New holding15,000
LHDavid Dreman 2014-06-30 Sold Out -0.01%$98.21 - $104.67
($100.8)
$ 126.3225%Sold Out0
LHJohn Rogers 2014-03-31 Buy 1.2%$87.86 - $98.64
($92.69)
$ 126.3236%New holding1,027,635
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LH is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


LH: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KING DAVID PPresident & CEO 2015-07-01Sell50,000$121.783.73view
KING DAVID PPresident & CEO 2015-06-01Sell50,000$118.586.53view
MITTELSTAEDT ROBERT E JRDirector 2015-05-19Sell1,296$119.026.13view
Williams R SandersDirector 2015-05-11Sell965$118.057.01view
BELINGARD JEAN-LUCDirector 2015-04-29Sell1,542$123.12.62view
Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics 2015-04-23Sell1,394$126.56-0.19view
Brecher Mark ECMO, LabCorp Diagnostics 2015-03-31Sell20,625$126.98-0.52view
Boyle James T. Jr.EVP, COO 2015-03-03Sell1,237$123.72.12view
Williams R SandersDirector 2015-02-26Sell2,267$123.961.9view
HERRING JOSEPH LCEO of Covance Drug Division 2015-02-25Sell36,876$121.643.85view

Press Releases about LH :

Quarterly/Annual Reports about LH:

News about LH:

Articles On GuruFocus.com
John Hussman's Top Five New Buys in the First Quarter May 12 2015 
John Hussman Increases Portfolio in 1Q2015 May 04 2015 
Laboratory Corporation of America Holdings Q4 Earnings Beat Market Expectations Feb 24 2015 
Westport Buys Apparel Retailer Express During Q4 Feb 11 2015 
Investment Ideas from Guy Spier - Part 2 Jan 07 2015 
The Top Five Guru-Held Mid-Cap Stocks of Q2 Sep 04 2014 
LabCorp: A Leading Independent Diagnostic Laboratory Aug 22 2014 
Tom Gayner’s Top 5 New Portfolio Picks Aug 11 2014 
Top Five Guru-Owned Mid Cap Stocks Jun 18 2014 
John Rogers Comments on Laboratory Corp. of America Holdings May 07 2014 

More From Other Websites
Laboratory Corp Of America (LH) Earnings Report: Q2 2015 Conference Call Transcript Jul 28 2015
LabCorp Earnings Top, View Up; Covance Integration Goes On - Analyst Blog Jul 28 2015
Covance deal helps drive earnings, revenues up for LabCorp Jul 28 2015
Laboratory Corporation of America Holdings Earnings Call scheduled for 9:00 am ET today Jul 28 2015
LabCorp (LH) Tops Q2 Earnings Estimates, Misses on Revenues - Tale of the Tape Jul 28 2015
LabCorp Announces New Covance Leadership Jul 28 2015
Laboratory Corporation of America® Holdings Announces Record 2015 Second Quarter Results and Raises... Jul 28 2015
LABORATORY CORP OF AMERICA HOLDINGS Files SEC form 8-K, Change in Directors or Principal Officers Jul 28 2015
LabCorp Announces New Covance Leadership Jul 28 2015
LabCorp tops Street 2Q forecasts Jul 28 2015
LabCorp tops Street 2Q forecasts Jul 28 2015
7:12 am Laboratory Corp beats by $0.06, beats on revs; guides FY15 EPS above consensus Jul 28 2015
Q2 2015 Laboratory Corporation of America Holdings Earnings Release - Before Market Open Jul 28 2015
Laboratory Corporation of America® Holdings Announces Record 2015 Second Quarter Results and Raises... Jul 28 2015
Will LabCorp (LH) Keep its Earnings Streak Alive in Q2? - Analyst Blog Jul 24 2015
Covance Opens Fit-for-Purpose Dallas Clinical Research Unit Jul 23 2015
LABORATORY CORP OF AMERICA HOLDINGS Files SEC form 8-K, Regulation FD Disclosure Jul 23 2015
Covance Opens Fit-for-Purpose Dallas Clinical Research Unit Jul 23 2015
LH supports Visium Asset Management. PRGO Drags Jul 17 2015
A second FDA approval frees Theranos to do a blood test outside lab Jul 16 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK